谷歌浏览器插件
订阅小程序
在清言上使用

51. the Comparative Effectiveness of Natalizumab and Anti-CD20 Monoclonal Antibodies in Relapsing-Remitting Multiple Sclerosis: A Real-World Based Study

Multiple Sclerosis and Related Disorders(2024)

引用 0|浏览0
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要